CHAMPIONS ONCOLOGY, INC. Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit
CHAMPIONS ONCOLOGY, INC. (CSBR) had Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit of $0 as of 2025-01-31, per its 10-Q filed 2025-03-17.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit · last filed 2025-03-17
- 2025-01-31: Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit $0.00.
- 2024-10-31: Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit $0.00.
- 2024-07-31: Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit $0.00.
- 2024-01-31: Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit $0.00.
| Period end | Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit |
|---|---|
| 2025-01-31 | $0.00 10-Q · filed 2025-03-17 |
| 2024-10-31 | $0.00 10-Q · filed 2024-12-16 |
| 2024-07-31 | $0.00 10-Q · filed 2024-09-13 |
| 2024-01-31 | $0.00 10-Q · filed 2024-03-15 |
| 2023-10-31 | $0.00 10-Q · filed 2023-12-13 |
| 2023-07-31 | $0.00 10-Q · filed 2023-09-13 |
| 2023-01-31 | $0.00 10-Q · filed 2023-03-16 |
| 2022-10-31 | $0.00 10-Q · filed 2022-12-13 |
| 2022-07-31 | $0.00 10-Q · filed 2022-09-12 |
| 2022-01-31 | $0.00 10-Q · filed 2022-03-15 |
| 2021-10-31 | $0.00 10-Q · filed 2021-12-13 |
| 2021-07-31 | $0.00 10-Q · filed 2021-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |